Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.

about

Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.

Item

http://www.wikidata.org/entity/Q52653741

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Therapy optimization in patien ...... lator in a real-world setting.

@en

Therapy optimization in patien ...... lator in a real-world setting.

@nl

type

Item

label

Therapy optimization in patien ...... lator in a real-world setting.

@en

Therapy optimization in patien ...... lator in a real-world setting.

@nl

prefLabel

Therapy optimization in patien ...... lator in a real-world setting.

@en

Therapy optimization in patien ...... lator in a real-world setting.

@nl

P1476

Therapy optimization in patien ...... lator in a real-world setting.

@en

P2093

Anna Hohneck

http://www.w3.org/2001/XMLSchema#string

Boris Rudic

http://www.w3.org/2001/XMLSchema#string

Erol Tülümen

http://www.w3.org/2001/XMLSchema#string

Jürgen Kuschyk

http://www.w3.org/2001/XMLSchema#string

Ksenija Stach

http://www.w3.org/2001/XMLSchema#string

Stefanie L Rosenkaimer

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).

Outpatient treatment with the wearable cardioverter defibrillator: clinical experience in two Dutch centres.

Wearable cardioverter defibrillator: Bridge or alternative to implantation?

Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Wearable defibrillator use in heart failure (WIF): results of a prospective registry

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death

Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.

P2888

s12872-018-0790-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12872-018-0790-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101545214

http://www.w3.org/2001/XMLSchema#string

P698

29544442

http://www.w3.org/2001/XMLSchema#string

P921

defibrillator

heart failure

P932

5856002

http://www.w3.org/2001/XMLSchema#string